ARTICLE | Clinical News
KBPA101 regulatory update
July 31, 2006 7:00 AM UTC
The EC granted Orphan Drug designation to KBPA101 to treat pneumonia caused by serotype O11 Pseudomonas aeruginosa. The human monoclonal antibody against P. aeruginosa is in Phase II testing. ...